Major drugmakers are set to raise the price of hundreds of drugs in the U.S., despite pressure from the Trump administration to cut prices.
Costs of at least 350 branded medications, including vaccines against Covid-19, shingles and cancer treatment Ibrance, will be hiked – some beginning from January 1, according to data provided to Reuters by healthcare research firm 3 Axis Advisors.
